Targeted in vitro and in vivo delivery of diagnostic and chemotherapeutic agents to prostate cancer cells pre-targeted with bispecific antibody-ligand complexes
Current standard cancer therapies include surgery, chemotherapy and radiation therapy. Although surgery is generally effective in the treatment of primary cancerous lesions, surgical resection of malignant tumors may not result in complete cure. By the time a tumor is detected by the existing diagno...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d20002441 |